Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 8/20 | 0.47 |
| ▸ | EGFR | P00533 | 15/20 | 0.45 |
| ▸ | ERBB4 | Q15303 | 4/20 | 0.45 |
| ▸ | SRC | P12931 | 3/20 | 0.41 |
| ▸ | KDR | P35968 | 3/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7233687 | 0.80 | AURKA (0.51) | ERBB2EGFRERBB4SRCKDR | |
| SCHEMBL7242049 | 0.80 | EGFR (0.61) | ERBB2EGFRERBB4SRCKDR | |
| SCHEMBL7244702 | 0.80 | EGFR (0.48) | ERBB2EGFRERBB4SRCKDR | |
| SCHEMBL7121729 | 0.79 | EGFR (0.49) | ERBB2EGFRERBB4SRC | |
| SCHEMBL7125412 | 0.77 | EGFR (0.48) | ERBB2EGFRERBB4SRC | |
| SCHEMBL7242855 | 0.76 | EGFR (0.65) | ERBB2EGFRERBB4 | |
| SCHEMBL7242169 | 0.74 | ERBB2 (0.51) | ERBB2EGFRERBB4KDR | |
| SCHEMBL7117608 | 0.72 | EGFR (0.54) | ERBB2EGFRERBB4 | |
| SCHEMBL7130805 | 0.72 | AURKA (0.44) | ERBB2EGFRERBB4SRCKDR | |
| SCHEMBL7237483 | 0.71 | EGFR (0.63) | ERBB2EGFRERBB4SRCKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6127374-A | AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS | WARNER-LAMBERT COMPANY (US) | 2000-10-03 | — | — | US | claimed |
| US-6562818-B1 | For treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis | WARNER-LAMBERT COMPANY | 2003-05-13 | — | — | US | disclosed |
| US-6127374-A | AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS | WARNER-LAMBERT COMPANY (US) | 2000-10-03 | — | — | US | disclosed |